India has found immense success in fighting life-threatening diseases like tuberculosis, malaria, lymphatic filariasis, and more. With such success, the country is all set to play a vital role in determining whether new drugs, vaccines, and other prevention tools can be deployed effectively and affordably to eliminate all such diseases from the world! This amazing news has been declared by the Bill & Melinda Gates Foundation. India will play an important role in determining whether Sustainable Development Goals (SDGs) can be achieved. This was confirmed at a lecture organized by the Department of Biotechnology, Biotechnology Industry Research Assistance Council, and the AIIMS. This is all thanks to the amazing education and training that is provided by reputed institutes across the country. You can also attain such exclusive training at Avigna Clinical Research Institute, the best clinical research online training institute in Bangalore. So, if clinical research and healthcare is your passion, enroll yourself right away!
What was the lecture about?
The lecture was titled “Innovating for Impact: How India can lead in helping solve some of the world’s toughest health challenges”. It primarily focused on India’s potential in addressing global health issues, and the challenges and opportunities that lie ahead. This lecture was attended by global leaders from various domains, where they shared their experienced and interacted with the scientific community.
How has this been possible?
This has been possible due to India’s huge size and population that carries a major portion of the world’s disease burden. India thus will play a crucial role in biotechnology and artificial intelligence that will determine the manufacturing of newer tools and technologies, which can help the country achieve health equity, and take leadership in addressing global health challenges. After all, no other country across the world’s emerging economies has the same combination of world-class biomedical research, effective translational research expertise, capacity to design and implement highly powered clinical trials, and capacity to produce health products that meet the stringent regulatory standards of the WHO, other than India!
India and its healthcare challenges
India definitely has 1 million missing cases of tuberculosis, but it also has the opportunity to develop improved solutions for tuberculosis case finding and reporting, along with treatment adherence. Another challenge that the country faces is that of nutrition. But, the National Nutrition Mission has set the goal of reducing the percentage of stunted children from 38.4% to 25% by the end of the year 2022.
ALSO READ: India Has Begun The Clinical Trial Of A New Tuberculosis Vaccine For Adults
India’s collaboration with international partners
India is collaborating extensively with many international partners in new areas to deal with the emerging healthcare challenges. Considering the high costs involved with healthcare, the collaboration is important to be taken up for frugal innovations so that efficient and affordable treatment strategies, relevant to the developing world and emerging markets, can be brought about. After all, access to affordable health technology remains a massive challenge not just in developing countries, but also in the developed ones, where pressure on the healthcare budget is immense.
